Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

stress conferences 2018

About Conference

Conferenceseries  welcomes you to attend the International Conference on Stress Diseases and Medicine, during October 24-25, 2018 at Boston, USA. We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Biotechnology and its applications with the theme Exploring Latest Innovations and Advances in Stress Diseases & Medicine.

This Stress 2018 conference creates a platform for Policy-makers, Scientists, representatives and decision makers in Stress Diseases and Diagnosis to present their latest research and learn about all the important developments in Stress Diagnosis. The Main agenda of Stress 2018 include therapeutics, Oxidative Stress, Redox Regulation & Modulation and Redox-Active Agents, Oxidative Stress & Biomarkers: Imaging of Oxidative Stress, Oxidative Stress & Stem Cells, Positive Effects of Stress, Negative Effects of Stress, Effects of antioxidants, and energy production, Oxidative Stress, Ageing & Longevity, Anti-Oxidants as Medicine and Others topics related to Stress & Antioxidants . Stress 2018 is an excellent opportunity for the delegates from Universities, Hospitals and Institutes to interact with the world class Scientists and latest research on the Diagnosis of Stress Diseases.

Target Audience:

  • Target Audience will be personnel from both industrial and academic fields which include; CEOs, COOs, Directors, Vice Presidents, Co-directors, Managing Directors, Industry Safety Officers, Doctors, Doctorates, Professors, Post Doctorate Fellows, Vendors of Consumer Products/ Managers, Stress relieving Equipment Manufactures, Pharmaceutical Scientists, Students from the related fields.

Market Analysis

It is with great pleasure that we welcome you to the official website of the 5th International Conference on Stress Diseases and Medicine during October 24-25, 2017 at Boston, USA.

Stress Diseases and Medicine Conference Market Analysis


Stress is a feeling of strain and pressure. Stress is the body’s normal reaction to daily events. Excessive amounts of stress, however, may lead to bodily harm. Stress can increase the risk of strokes, heart attacks, ulcers, dwarfism, and mental illnesses such as depression. Stress originates from alternate sources of a different nature, such as physical, social, passionate, psychological, etc. A stressful event can either be an upsetting one (getting fired, going through a divorce, the loss of a loved one, etc.) or a happy one (wedding, birth, travel, etc.).The stimulus can be either minor or very significant, and either temporary or chronic. We don’t all react the same way to sources of stress, so it is important to identify what your stress triggers are to better face them.

Market Analysis

Stress & Depression, Anxiety Disorders Treatment Market worth $248.3 billion by 2025.

According to a report, the global anxiety disorders and depression treatment market will demonstrate a mediocre CAGR of 1.25% during the forecast period of 2014 to 2020. In 2013, the global anxiety disorders and depression treatment market stood at US$172.5 bollion 2016 and is projected to reach USD 228.6 billion 2020.

According to WHO, currently an estimated 350 million people globally are affected with depression, anxiety and stress. The primary driver of the global anxiety disorders and depression treatment market is the accelerating prevalence of depression and anxiety disorders.

Other factors driving the global anxiety disorders and depression treatment market are rising geriatric population and increasing efficacy and decreasing side effects of drugs in several classes. According to the World Health Organization (WHO), to date, over 350 million people have been affected by depression globally. The Anxiety and Depression Association of America revealed that at present approximately 40 million people in the U.S. are suffering from anxiety disorder and treating these patients costs around USD 42 billion each year.

Nearly 50% of the women with early breast cancer had depression, anxiety, stressed or both in the year after diagnosis, 25% in the second, third, and fourth years, and 15% in the fifth year.  45% of those with recurrence experienced depression, anxiety, or both within three months of the diagnosis.

Point prevalence of depression, anxiety, or both (including borderline cases) was 33% at diagnosis and 24% at three months after diagnosis, dropping to 15% at one year (figure). The annual prevalence’s for the first to fifth years after diagnosis were 48%, 25%, 23%, 22%, and 15%, respectively.




To Collaborate Scientific Professionals around the World

Conference Date October 24-25, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Journal of Depression and Anxiety

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner